What Terumo Cardiovascular Systems does

Terumo Medical Corporation (TMC) is the North American subsidiary of Terumo Corporation (TSE:4543), a Tokyo-based medical technology company founded in 1921. Established in the US in 1972 and headquartered in Somerset, New Jersey, TMC operates four divisions spanning interventional systems, injection/infusion therapy, pharmaceutical solutions, and digital health outcomes. Its portfolio includes introducer sheaths, guidewires, balloon and microcatheters, closure devices, carotid and peripheral stents, embolization coils, and the OPUSWAVE dual sensor intravascular imaging system, serving cardiac catheterization labs, interventional radiology suites, and vascular surgery departments globally.

The company differentiates through proprietary technologies including SafeR passive safety retraction for syringes, i-coating silicone oil-free stopper technology, PLAJEX cyclo olefin polymer pre-fillable syringes for ophthalmic and biopharmaceutical applications, WEB microbraid intrasaccular aneurysm treatment devices, and the ePRISM clinical decision support platform that applies validated predictive analytics to calculate patient-specific contrast limits and AKI risk during PCI procedures. Manufacturing operations span Elkton, Maryland; Caguas, Puerto Rico; and Vaughan, Ontario, supported by ISO 13485 quality certification maintained since 1995.

Revenue derives from B2B medical device hardware sales to hospitals and healthcare systems via enterprise direct sales forces, GPO contracts, and authorized distributor networks, supplemented by digital health subscription revenue through ePRISM, licensing/royalty arrangements from strategic partnerships, and pharmaceutical solution design services. Products reach over 160 countries through multi-channel distribution including online ordering portals, field sales teams, and channel partners. The broader Terumo Corporation parent reported approximately JPY 600-629 billion ($5.5B USD) in recent annual revenue, with TMC representing a significant North American segment through its 2,000+ North America associates out of the group's 30,000+ global workforce.

Name

Terumo Cardiovascular Systems

Legal name

Terumo Medical Corporation

Website

https://terumomedical.com

Company type

Public

Founded year

1972

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Terumo Medical Corporation is the North American subsidiary of Terumo Corporation, manufacturing cardiovascular interventional devices, injection/infusion therapy products, pharmaceutical delivery systems, and the ePRISM clinical decision support platform for hospitals, clinics, and pharmaceutical companies across 160+ countries.

Ownership category

akta.pro rank

Product category

Cardiovascular Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation) (HLAHAFAL)

Keywords

• Interventional cardiology devices
• Vascular access products
• Injection infusion devices
• Prefillable syringe systems
• Clinical decision support software

Headquarters

HQ city

Somerset

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Direct sale of medical devices including interventional systems, injection and infusion therapy devices, and pharmaceutical delivery solutions to healthcare providers and institutions.
2. Strategic Partnership Payments: $30 million payment from Terumo to Orchestra BioMed including right of first refusal for Virtue SAB, plus $20 million preferred stock investment. Revenue from co-development and licensing arrangements.
3. Digital Health Solutions: Software and clinical decision support solutions through ePRISM platform, providing predictive analytics to healthcare systems for quality improvement and cost reduction.
4. Pharmaceutical Solutions Services: Product design and development services for pharmaceutical companies, including pre-fillable syringe solutions and drug delivery technologies.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Terumo Cardiovascular Systems manufactures and sells interventional cardiology and vascular medical devices, injection and infusion therapy devices, pre-fillable pharmaceutical syringe systems, and clinical decision support software. Products are sold directly to hospitals, healthcare systems, and pharmaceutical companies through an enterprise field sales force and authorized distributor network across more than 160 countries, with U.S. operations headquartered in Somerset, New Jersey.

Product overview

Terumo Medical Corporation is a global medical device company organized into four divisions: Terumo Interventional Systems (TIS) provides cardiology and peripheral vascular solutions including introducer sheaths (GLIDESHEATH SLENDER, PINNACLE), balloon catheters (TAKERU PTCA, METACROSS, CROSSTELLA), guidewires (GLIDEWIRE ADVANTAGE, RUNTHROUGH NS), microcatheters, closure devices (TR BAND, ANGIO-SEAL), stent systems (ROADSAVER Carotid, R2P MISAGO), and coil embolization systems (AZUR HydroPack); Terumo Health Outcomes (THO) offers the ePRISM clinical decision support platform using predictive analytics for patient risk assessment during PCI procedures; Terumo Medical Products (TMP) manufactures injection and infusion devices including SurTract Safety Syringes, SurGuard safety needles, SurFlash I.V. catheters, and Surshield safety products; and Terumo Pharmaceutical Solutions (TPS) develops drug delivery devices including PLAJEX pre-fillable polymer syringes for pharmaceutical applications. The portfolio also includes the OPUSWAVE dual sensor imaging system and WEB embolization system through the MicroVention subsidiary for neurovascular procedures.

Differentiator

Problem solved

Functional benefit

Brands

• Terumo Interventional Systems (TIS): Market leader in providing solutions for minimally invasive entry site management, lesion access and therapeutic intervention for cardiology, peripheral arterial disease, embolotherapy and interventional oncology.
• Terumo Health Outcomes (THO)
• Terumo Medical Products (TMP)
• Terumo Pharmaceutical Solutions (TPS)
• OPUSWAVE
• DualView
• SurTract
• TR BAND
• AZUR
• GLIDESHEATH SLENDER
• ePRISM
• PLAJEX
• ROADSAVER
• WEB (Woven EndoBridge)

Products and services

• SurTract Safety Syringe Retractable safety hypodermic syringe featuring SafeR passive safety technology that automatically withdraws the needle into the plunger immediately after use, designed for hospitals, clinics, and emergency-care settings to reduce needle-stick injuries. FDA 510(k)-cleared and compliant with ISO 11040-7 and ISO 23908.
• OPUSWAVE Dual Sensor Imaging System and DualView Imaging Catheter Dual sensor intravascular imaging system paired with DualView imaging catheter providing comprehensive visualization during interventional cardiology and vascular procedures for hospitals and cath labs.
• R2P NaviCross Peripheral Support Catheter Radial-to-Peripheral support catheter designed for peripheral intervention procedures via radial access, for use in hospital interventional radiology and vascular surgery departments.
• AZUR HydroPack Peripheral Coil System Peripheral coil embolization system providing soft-packing, long-lasting solution for embolotherapy procedures in interventional radiology.
• GLIDESHEATH SLENDER Introducer Sheath Introducer sheath designed for radial access procedures with slender profile for reduced vascular trauma, used by interventional cardiologists in cath labs.
• PINNACLE Introducer Sheath Introducer sheath for vascular access during interventional procedures, providing femoral or radial access for hospitals and cath labs.
• TR BAND Radial Compression Device Radial compression device for hemostasis following transradial catheterization procedures, used in cath labs for post-procedure patient management.
• ANGIO-SEAL VIP Vascular Closure Device Vascular closure device for sealing femoral access sites after catheterization procedures in hospital interventional settings.
• ROADSAVER Carotid Stent System Carotid stent system designed for carotid artery stenting procedures performed by interventional cardiologists and vascular surgeons.
• R2P MISAGO RX Self-Expanding Peripheral Stent Self-expanding peripheral stent for radial-to-peripheral procedures in peripheral arterial disease treatment.
• TAKERU PTCA Balloon Dilatation Catheter PTCA balloon catheter for coronary artery angioplasty procedures in hospital cath labs.
• FINECROSS M3 Coronary Micro-Guide Catheter Coronary micro-guide catheter for complex coronary interventions performed in hospital cath labs.
• RUNTHROUGH NS Coronary Guidewire Coronary guidewire available in Extra Floppy, HYPERCOAT, and IZANAI variants for different lesion characteristics during PCI procedures.
• GLIDEWIRE ADVANTAGE Hydrophilic Coated Guidewire Hydrophilic coated guidewire for peripheral and coronary interventions with enhanced trackability for hospital interventional procedures.
• SurFlash Polyurethane I.V. Catheters Polyurethane I.V. catheters with visual flashback confirmation feature for easy placement verification in hospitals and clinics.
• Surshield Safety Winged Blood Collection Sets Safety winged blood collection sets with one-handed activation for needlestick injury prevention during blood collection in hospitals and labs.
• SurGuard 3 Safety Needle Safety needle with three activation methods and broad size range for adaptability in clinical settings across hospitals and clinics.
• ePRISM Clinical Decision Support Platform Precision medicine software platform providing predictive patient analytics using validated risk models to calculate patient-specific contrast limits and prevent acute kidney injury during PCI procedures. Sold to hospitals and healthcare systems for improving PCI outcomes.
• PLAJEX Pre-fillable Polymer Syringe Silicone oil-free pre-fillable syringe using Cyclo Olefin Polymer (COP) with i-coating stopper technology, designed for low-dose applications such as ophthalmic drugs including intravitreal injections. Sold to pharmaceutical and biotech customers for drug delivery device manufacturing.
• WEB Embolization System Intrasaccular flow disruptor device for treating intracranial wide neck bifurcation aneurysms, using proprietary microbraid technology that self-expands to conform to aneurysm shape. Sold to neurovascular centers and hospitals for aneurysm treatment.
• Terumo Pharmaceutical Solutions (TPS) Drug Delivery Design and Development Services Comprehensive product design and development services offering pharmaceutical and medical device companies drug delivery device expertise and pre-fillable syringe solutions.
• VitalStream Non-Invasive Hemodynamic Monitoring (Distributed) Distribution arrangement for Caretaker Medical's VitalStream non-invasive hemodynamic monitoring product distributed by Terumo Health Outcomes to hospitals and healthcare systems.

Quantifiable outcome

• Reduction in contrast volume exceeding safe limits from 51.7% to 38.1% when using ePRISM clinical decision support
• +1 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Roncadelle Operations S.r.l.coreTechnology or Integration · 6 January 2026Partnership for SafeR passive safety technology integration into SurTract Safety Syringe. Roncadelle develops and manufactures the technology; Terumo distributes the product. Technology provides automatic needle retraction to reduce needle-stick injuries. Products comply with ISO 11040-7 and ISO 23908, FDA 510(k)-cleared.
• Orchestra BioMedcoreStrategic or Co-development Partner · 28 October 2025Strategic agreement involving $30 million payment from Terumo including right of first refusal for Virtue SAB (Sirolimus-Eluting Balloon) for coronary artery disease treatments. Includes $20 million investment by Terumo in Orchestra BioMed through preferred stock. Ongoing development of Virtue SAB and other cardiovascular therapies.
• Caretaker MedicalminorChannel Partner/ Reseller/ Distributor · 9 July 2025Distribution agreement for Caretaker Medical's VitalStream non-invasive hemodynamic monitoring product through Terumo Health Outcomes. Terumo distributes the monitoring solution to hospitals and healthcare systems as part of its health outcomes portfolio.
• Corazon, Inc.minorGTM or Marketing Partner · 25 February 2022Collaboration and co-marketing agreement combining Terumo Health Outcomes' ePRISM technology with Corazon's accreditation services. Partnership aims to deliver predictive analytics integrated with cardiac care program accreditation to improve patient outcomes and healthcare efficiency.

Scale indicators5 records

Recent moves11 records

Expansion highlights6 records

Direct peers

• Boston Scientific: Boston Scientific is a direct peer in interventional cardiology and peripheral vascular (Ranger DCB, Eluvia DES), embolization (Interlock), and cardiology imaging — overlapping nearly every Terumo Cardiovascular product category.
• Penumbra: Penumbra is a direct peer in neurovascular and peripheral vascular thrombectomy/embolization, overlapping with Terumo MicroVention's WEB Embolization System and AZUR peripheral coil portfolio.
• Medtronic: Medtronic is a direct peer through its Cardiovascular Portfolio, competing head-to-head across interventional cardiology (resolute stents, IN.PACT DEB), cardiac surgery, and structural heart products distributed globally through enterprise hospital sales.
• Teleflex: Teleflex is a direct peer in interventional cardiology access (Arrow catheters), anesthesia, and specialty surgical devices, with overlapping radial access and guide catheter product portfolios to Terumo Interventional Systems.
• Edwards Lifesciences: Edwards is a direct peer in cardiovascular, particularly transcatheter heart valves (Sapien), critical care monitoring, and surgical aortic repair — addressing the same cardiac surgery and interventional cardiology buyers.
• ICU Medical: ICU Medical is a direct competitor in IV therapy, infusion pumps, needle-free connectors, and pre-fillable syringes following its Smiths Medical acquisition, targeting the same hospital and pharmaceutical customer base as Terumo Medical Products.
• Abbott Cardiovascular: Abbott competes directly with Terumo in coronary intervention (XIENCE stents), vascular closure, and structural heart, with comparable enterprise sales models targeting the same hospital cardiology departments.
• Merit Medical Systems: Merit Medical directly competes with Terumo Interventional Systems in guidewires, catheters, embolization, and radial access accessories, serving identical interventional radiology and cardiology departments with similar sales channels.

Broad incumbents

• Cardinal Health (Cordis): Cordis, within Cardinal Health, is a broad incumbent peer in interventional cardiology and vascular access (MynxGrip closure, Railway sheaths), competing directly with Terumo's radial access and vascular closure franchises in the same hospital channels.
• Becton Dickinson (BD): BD competes broadly with Terumo Medical Products in injection and infusion therapy (BD Nexiva, BD Insyte), safety needles, and pre-fillable pharmaceutical systems — overlapping on TMP and TPS product lines through BD Medical and BD Pharmaceutical Systems.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Terumo Cardiovascular Systems